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Abstract
Background: Though the prevalence of dementia among hospitalized patients is increasing, there is limited
population data in Europe about the use of life-support measures such as invasive mechanical ventilation in
these patients. Our objective is to assess whether dementia influences the incidence, outcomes, and hospital
resource use in elderly patients undergoing mechanical ventilation.
Methods: Using ICD-9-CM codes, all hospitalizations involving invasive mechanical ventilation in adults aged
≥ 65 years were identified in the Spanish national hospital discharge database covering the period 2000–2013.
The cases identified were stratified into two cohorts (patients with or without dementia) in which main
outcome measures were compared. The impact of dementia on in-hospital mortality and hospital resource
use were assessed through multivariable models. Trends were assessed through joinpoint regression analysis
and results expressed as average annual percentage change.
Results: Of the 259,623 cases identified, 5770 (2.2%) had been assigned codes for dementia. Cases with
dementia were older, had a lower Charlson comorbidity score, and less frequently received prolonged
mechanical ventilation or were assigned a surgical DRG. Circulatory disease was the most common main
diagnosis in both cohorts. No significant impact of dementia was observed on in-hospital mortality (adjusted
OR 1.04, [95% CI] 0.98, 1.09). In the cohort with dementia, the incidence of mechanical ventilation underwent
an average annual increase over time of 5.39% (95% CI 4.0, 6.7) while this rate was 1.62% (95% CI 0.9, 2.4) in
cases without dementia. However, unlike this cohort, mortality in cases with dementia did not significantly
decline over time. Geometric mean hospital cost and stay were lower among cases with than without
dementia (− 14% [95% CI − 12%, − 15%] and − 12% [95% CI, − 9%, − 14%], respectively), and these differences
increased over time.
Conclusion: This nationwide population-based study suggests no impact of dementia on in-hospital mortality
in elderly patients undergoing invasive mechanical ventilation. However, dementia is significantly associated
with shorter stay and hospital costs. Our data also identifies a recent marked increase in the use of this life-
support measure in elderly patients with dementia and that this increase is much greater than that observed
in elderly individuals without dementia.
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Background
Dementia is one of the greatest health problems among
persons aged 65 years or older worldwide. Because of
population aging and a lack of effective prevention and
treatment measures, it has been estimated that in the
foreseeable future, the number of affected persons will
double [1, 2].
The prevalence of dementia among hospitalized patients
is also increasing [3–5], but the balance of potential bene-
fits and harm of intensive care interventions in this popu-
lation is unclear. In fact, the last few years have witnessed
intense debate regarding life-support intensive treatment
in patients with dementia such as invasive mechanical
ventilation (MV) [6–9]. MV is a key component of the
management of critically ill patients with acute or chronic
respiratory failure. However, it is associated with a high
mortality [10], with short- and long-term complications
[11, 12], and requires a complex care level with a substan-
tial impact on hospital resources [13].
Despite these considerations, few studies have exam-
ined trends in its use in patients with dementia. The
scarce data available come from the USA and Canada
where several authors have reported a sustained in-
creased use of MV in patients with dementia in the past
few decades [14, 15] with clinical outcomes comparable
to those observed in patients without dementia [16].
Spain is a rapidly aging country and dementia preva-
lences are among the highest in the world (https://www.
alzheimer-europe.org/Policy-in-Practice2/Country-com-
parisons/2013-The-prevalence-of-dementia-in-Europe/
Spain). This determines the need to characterize the use
of MV and its trends in these patients since the use of
effective and safe therapeutic technologies and the ap-
propriate use of healthcare resources are priority objec-
tives in a quality health system. Accordingly, this study
sought to examine the characteristics of MV and its
recent trends in incidence, associated mortality, and hos-
pital resource use in patients ≥ 65 years with and without
dementia based on data from Spain’s national hospital
discharge database.
Methods
Study design and data sources
We performed a retrospective population-based study
using the Spanish Health Ministry’s National Minimum
Basic Data Set (MBDS). This official database gathers
information derived from discharge reports from all
acute-care hospitals in Spain. For each hospitalization,
demographic and clinical information is provided includ-
ing a main diagnosis, 13 secondary diagnoses, and up to
20 procedures coded at each center before patient dis-
charge according to International Classification of Dis-
eases, Ninth Edition, Clinical Modification (ICD-9-CM)
codes as well as corresponding diagnosis-related group
(DRG) codes. This information, whose registration is
mandatory by law in the National Health System, is con-
sidered to be representative of the national population
as the database covers over 90% of all annual hospital
admissions produced in our country [17].
To calculate incidence rates, we used population data
provided by the Spanish Statistics Institute [18]. Hospital
admissions data were provided by the Ministry of
Health, Resources and Welfare [17]. All data used are
anonymous so, according to Spanish law, the need was
waived for informed consent [19].
Study population: case definitions and identification
Hospitalizations involving subjects ≥ 65 years who re-
ceived MV from January 1, 2000, to December 31, 2013,
were identified using the ICD-9-CM codes: 96.70 (con-
tinuous invasive MV of unspecified duration), 96.71 (con-
tinuous invasive MV < 96 consecutive hours) and 96.72
(continuous invasive MV ≥ 96 consecutive hours). These
codes are considered specific, stable, and valid [20].
According to ICD-9-CM coding norms, one of these
codes is assigned to hospitalized patients who require
MV except if used during a routine surgical procedure.
Postsurgery MV is coded if lasting more than 2 days or
if the clinician reports its duration was longer than
planned. MV duration was measured from the moment
of endotracheal intubation [17].
Dementia is a clinical syndrome characterized by a
global, progressive cognitive impairment that generates
functional decline and disability [21]. A variety of brain-
damaging conditions, such as degenerative, vascular,
metabolic, or toxic brain disease, can lead to dementia,
and although the most frequent cause of dementia from
middle age to elderly is Alzheimer’s disease, most pa-
tients suffer from a mixture of different pathologies [21].
We defined dementia as the presence in any of the diag-
noses entered in the database of the ICD-9-CM codes:
290.0–290.9 (dementias), 291.1 (alcohol-induced persist-
ing amnestic disorder), 291.2 (alcohol-induced persisting
dementia), 292.82 (drug-induced persisting dementia),
292.83 (drug-induced persisting amnestic disorder),
294.0 (amnestic disorder in conditions classified else-
where), 294.1 (dementia in conditions classified else-
where), 294.2 (dementia, unspecified), 294.8 (other
persistent mental disorders due to conditions classified
elsewhere), 294.9 (unspecified persistent mental disor-
ders due to conditions classified elsewhere), 331.0 (Alz-
heimer’s disease), 331.1 (frontotemporal dementia),
331.2 (senile degeneration of the brain), 331.7 (cerebral
degeneration in diseases classified elsewhere), 331.82
(dementia with Lewy bodies), and 331.9 (cerebral degen-
eration, unspecified). Similar broad definitions of de-
mentia have been used by others [14] to improve case
detection.
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To assess the comorbidity burden, we used the Charl-
son index score validated by Deyo [22] and improved for
ICD-9-CM [23] according to secondary diagnoses. For
the purposes of this study, dementia itself was excluded
in the Charlson Index [24].
For every case, the main diagnostic group was assessed
according to the ICD-9-CM chapters: infectious disease
(001–139), neoplasms (140–239), endocrine diseases
(240–279), hematological diseases (280–289), neuro-
logical diseases (320–389), diseases of the circulatory
system (390–459), respiratory diseases (460–519), dis-
eases of the digestive system (520–579), diseases of the
genitourinary tract (580–629), diseases of the skin and
subcutaneous tissue (680–709), diseases of the musculo-
skeletal system and connective tissue (713–739), and
injury-poisoning (800–999).
Data analysis
We conducted a descriptive and comparative analysis of
cases with and without dementia, including demographic
and clinical information, comorbidity burden, and hos-
pital mortality, stay, and costs. Charlson comorbidity
scores are provided as a continuous variable and as cat-
egorical with 4 groups (0, 1–2, 3–4, > 4) of increasing
severity and impact on outcomes [25]. Categorical vari-
ables are expressed as absolute frequencies and percent-
ages while continuous variables are given as geometric
means and geometric standard deviation (SD), as geo-
metric means are less influenced by extreme values than
arithmetic ones. To test differences in categorical vari-
ables, we used Pearson’s chi-square test.
In-hospital mortality was estimated as the number of
deaths relative to the number of cases and expressed as
a percentage, or case fatality rate (CFR). To examine the
effect of dementia on mortality, stay, and costs, we con-
ducted regression models (logistic regressions for mor-
tality and linear regressions of log-transformed stay and
costs) and adjusted them in two multivariable models.
Model 1 was adjusted for baseline characteristics (age,
sex, Charlson index) whereas model 2 also included
the principal diagnosis at admission and MV duration.
Results are expressed as odds ratios (OR) with 95%
confidence intervals (for mortality) and geometric
means ratio with 95% confidence intervals (for stays
and costs).
We examined temporal trends in MV incidence rate
(per 100,000 people and per 10,000 hospital discharges),
proportion of MV cases with dementia, prolonged MV
(defined as a duration of ≥ 96 consecutive hours accord-
ing to the ICD-9-CM codification system), and CFR. To
this end, we used joinpoint regression models—general-
ized linear models that assume a Poisson distribution
[26]. In these models, any apparent trend can be statisti-
cally assessed through a Monte Carlo permutation method
[27]. Trends are presented as the average annual percentage
change (AAPC), a summary measure of the overall trend
over the study period. To compare the AAPC of both study
groups, we examined whether their regression mean func-
tions were parallel, allowing for different intercepts, using
the Pairwise comparison parallel test. In addition, we ana-
lyzed trends in length of stay and costs using Cuzick’s p-
trend test.
All tests were performed using the packages STATA
15 (StataCorp. LP, College Station, TX, USA) and
Joinpoint Regression 4.7.0.0. Significance was set at
p < 0.05.
Results
Out of the 19,979,322 hospitalizations in persons aged ≥
65 years produced over the 14-year study period, 259,
623 cases underwent MV. Of these, 5770 (2.2%) were
cases with dementia.
As may be seen in Table 1, in the dementia cohort,
the proportions of women and older age strata were
higher than in the cohort without dementia. The
Charlson score, however, was lower indicating a lower
comorbidity burden among those with dementia.
Among the main comorbidities, we should highlight a
greater presence of cerebrovascular disease in the
group of patients with dementia. Circulatory disease
was the most common main diagnosis in both co-
horts and was followed with disparate frequency in
each one by respiratory disease, injury-poisoning, and
digestive disorders. Conversely, cancer was much less
frequent in the cases with dementia. Registries includ-
ing dementia corresponded more to smaller hospitals,
and patients less frequently received prolonged MV
or were assigned a surgical DRG than in the non-
dementia group. The cohort with dementia showed a
slightly, yet significantly, higher in-hospital mortality,
and this difference was attributable only to cases
subjected to short-duration MV (Additional file 1:
Table S1). However, as may be observed in Table 2,
according to the logistic regression analysis adjusted
for age, sex, comorbidity burden, main diagnosis, and
MV duration, dementia had no significant impact on
in-hospital mortality.
Among the survivors, 78% of cases with dementia and
81% of those without dementia were discharged home
while 16.3% and 15.1% respectively were discharged to
long-term care centers.
Both geometric mean stay and hospital costs for the
dementia group were significantly lower than for the
non-dementia group (Table 2). Further, multivariate
analysis of the impacts of dementia on hospital resource
use indicated that dementia was associated significantly
with a shorter adjusted mean hospital stay and lower
mean hospital costs per case.
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Table 1 General characteristics of adults ≥ 65 years receiving invasive mechanical ventilation
With dementia Without dementia OR (95%CI) p value
5770 (2.2) 253,853 (97.8)
Gender women 2702 (46.8) 96,946 (38.2) 1.43 (1.35, 1.50) < 0.001
Age
65–74 years 1787 (31.0) 131,717 (51.9) Ref.
75–84 years 3166 (54.9) 108,990 (42.9) 2.14 (2.02, 2.27) < 0.001
> 84 years 817 (14.1) 13,146 (5.2) 4.58 (4.21, 4.99) < 0.001
Charlson Index score
0 points 1891 (32.8) 77,478 (30.5) Ref.
1–2 points 2932 (50.8) 124,467 (49.0) 0.97 (.91, 1.02) 0.235
3–4 points 734 (12.7) 37,678 (14.8) 0.80 (0.73, 0.87) < 0.001
> 4 points 213 (3.7) 14,230 (5.6) 0.61 (0.53, 0.71) < 0.001
Main Charlson comorbidities
Diabetes 1476 (25.6) 59,879 (23.6) 1.10 (1.03, 1.14) < 0.001
Cerebrovascular disease 1048 (18.2) 18,972 (7.5) 2.75 (2.57, 2.94) < 0.001
COPD 1005 (17.4) 54,918 (21.6) 0.76 (0.71, 0.82) < 0.001
Heart failure 836 (14.5) 47,921 (18.9) 0.73 (0.68, 0.78) < 0.001
ICD-9-CM main diagnosis
Circulatory 1751 (30.3) 98,683 (38.9) 0.69 (0.65, 0.73) < 0.001
Respiratory 984 (17.0) 39,379 (15.5) 1.12 (1.04, 1.20) 0.001
Injury-poisoning 910 (15.8) 27,338 (10.8) 1.55 (1.44, 1.67) < 0.001
Digestive 805 (14.0) 29,621 (11.7) 1.23 (1.14, 1.32) < 0.001
Cancer 364 (6.3) 29,229 (11.5) 0.52 (0.47, 0.58) < 0.001
No. of hospital beds
< 200 691 (12.0) 26,929 (10.6) Ref
200–500 1927 (33.4) 71,698 (28.2) 1.05 (0.96, 1.14) 0.302
501–1000 1774 (30.8) 87,898 (34.6) 0.79 (0.72, 0.86) < 0.001
> 1000 1378 (23.9) 67,327 (26.5) 0.80 (0.73, 0.87) < 0.001
DRG surgical 2455 (42.6) 145,001 (57.2) 0.56 (0.53, 0.59) < 0.001
Mechanical ventilation ≥ 96 h 1729 (30.0) 85,162 (33.6) 0.85 (0.80, 0.90) < 0.001
In-hospital mortality (CFR) 2992 (51.9) 123,445 (48.6) 1.14 (1.08, 1.20) < 0.001
Data presented as number of cases (%)
OR odds ratio, CI confidence interval, COPD chronic obstructive pulmonary disease, DRG diagnosis-related group, CRF case fatality rate
Table 2 Impact of dementia on in-hospital mortality and hospital resource use
With dementia Without dementia Crude Model 1 Model 2
(%) (%) OR (95% CI) Adjusted OR (95% CI)
CFR 51.9 48.6 1.14 (1.08, 1.20) 1.05 (0.99, 1.1) 1.04 (0.98, 1.09)
Geometric mean (SD) Geometric mean (SD) Ratio of geometric means (95% CI) Adjusted ratio of geometric means (95% CI)
Hospital stay, days 11.16 (3.20) 14.01 (3.19) 0.80 (0.77, 0.82) 0.85 (0.82, 0.87) 0.88 (0.86, 0.91)
Costs, € 10,423 (2.34) 12,855 (2.40) 0.81 (0.79, 0.83) 0.83 (0.81, 0.85) 0.86 (0.85, 0.88)
Model 1: adjusted for sex, age, Charlson index
Model 2: adjusted for sex, age, Charlson index, main diagnosis, and length of MV
CFR case fatality rate, SD standard deviation
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Temporal trends
Rates of MV use referred to hospital discharges and the
general population underwent a significantly greater in-
crease among the subjects with dementia compared to
those without (Table 3). In patients with dementia, the
rate of MV use per 10,000 hospital discharges went up
from 1.76 in 2000 to 3.57 in 2013, with an AAPC of
4.7%. Meanwhile, in patients without dementia, the rate
of MV use per 10,000 hospital discharges went up from
114.5 in 2000 to 131.3 in 2013 with an AAPC of 0.91%.
According to the comparability test, trends of MV in de-
mentia and non-dementia cases were different (p value
for test for parallelism = 0.005). The population inci-
dence of MV in people with dementia rose from 3.1 to
6.9 per 100,000 inhabitants ≥ 65 years, yielding an AAPC
of 5.39%, while in the non-dementia group it increased
from 203.6 to 253.3, for an AAPC of 1.62% (Fig. 1). Ac-
cording to the comparability test, population incidence
trends in dementia and non-dementia were also different
(p value for test for parallelism = 0.03).
Table 3 also provides temporal trends in the use of
VM ≥ 96 h and in-hospital mortality (CFR), indicating
that subjects with dementia underwent no significant
changes over the study period, while in the non-
dementia cohort the use of prolonged MV increased
and mortality decreased. As shown in Fig. 2, cases
with dementia have not followed the descending trend
shown by the cases without dementia; rather, mortal-
ity has fluctuated over time.
Figure 3 illustrates that geometric mean hospital stay
in the cohort with dementia has steadily declined over
time, while it has been relatively stable in the cohort
without dementia. Geometric mean hospital costs per
case have risen markedly over the study period. This in-
crease has been nevertheless lower among cases with de-
mentia, and inter-cohort differences have persisted
(Fig. 3).
Discussion
The findings of this population-based study indicate that
the use of MV in elderly persons diagnosed with demen-
tia has shown a marked increase in Spain between the
years 2000 and 2013. Further, this increase has been
higher than that observed in their dementia-free coun-
terparts. They also reveal that while no impacts of
dementia on hospital mortality were detected, the de-
clining trend in mortality produced in patients without
dementia was not observed. In addition, compared with
subjects free of dementia, these individuals incur lower
hospital costs and length of stay.
As far as we know, this is the first study to characterize
the pattern of MV use in adults ≥ 65 years with and with-
out dementia in a European country. The demographic
and clinical characteristics of our cases are similar to those
described in the USA and Canada [14, 15], although de-
mentia appears as notably less frequent among those
receiving MV in our setting. Only 2.2% of hospitalized
adults aged ≥ 65 years undergoing MV had been assigned
a code for dementia, contrasting with the 15% and the
8.6% rates described in those studies. Our results show in
the cohort of patients with dementia a marked increase in
the incidence of MV with an average annual increase of
5.39%, which is much higher than the 1.62% observed in
the cohort without dementia. Notwithstanding, the in-
crease detected was markedly lower than that reported by
Lagu (11.4%) and by Borjaille (7.8%) in adults ≥ 65 years
with dementia [14, 15]. In part, these differences could be
explained by the very different healthcare systems and the
organizational models used for the care of critically ill pa-
tients between countries [28]. We should not forget that
in a healthcare setting, offer is an important regulator
of demand. Effectively in the USA, the increased use
of MV in patients with advanced dementia has been
linked to a greater availability of beds in intensive
care units [29]. In Spain, with its universal, equal-
access healthcare system, it is estimated that in 2010
there were some 9.6 ICU beds per 100,000 inhabi-
tants [30, 31] while in the USA this was around four
times this figure in 2009 [32]. But, in spite of these
differences, our data are in line with those reported
in North America and contrast with prior studies in-
dicating that acute care patients with dementia are
treated substantially less aggressively than patients
without dementia [8].
Table 3 Trend analysis
MV in cases with dementia MV in cases without dementia Parallelism test
2000 2013 AAPC (95% CI) 2000 2013 AAPC (95% CI)
Proportion (%) 1.51 2.64 3.8 (3.0, 4.5)† 98.5 97.4 − 0.1 (− 0.1, − 0.1)† P < 0.001
Hospital discharge rate (per 10,000) 1.76 3.57 4.71 (3.6, 5.8)† 114 131 0.91 (0.4, 1.4)† P = 0.005
Population rate (per 100,000) 3.1 6.9 5.39 (4.0, 6.7)† 203.6 253.3 1.62 (0.9, 2.4)† P = 0.030
MV ≥ 96 h (%) 24.6 28.4 − 0.8 (− 2.3, 0.7) 31.2 34.9 0.99 (0.7, 1.3)† P = 0.031
CFR (%) 55.9 50.2 − 0.30 (− 1.1, 0.5) 51.9 44.5 − 1.19 (− 1.3, − 1.0)† P = 0.10
MV invasive mechanical ventilation, AAPC average annual percentage change, 95%CI 95% confidence interval, CFR: case fatality rate
†Statistically significant
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Our dementia group showed an older age and higher
percentage of women, as described by others [16]. How-
ever, our cases had a lower comorbidity burden which
could be partly due to the different score system used as
there is still no standardized method to assess this issue
despite its important role in patient’s outcomes [33]. For
this study, we selected the Charlson comorbidity index
as it has shown a similar capacity to scales based on
physiological scores to predict mortality in critically ill
patients [34].
As expected, in-hospital mortality was really high in
both cohorts. But, a main finding of our study was the
lack of significant differences in CFR between both co-
horts once adjusted for remaining clinical-demographic
variables, meaning that dementia has not had a signifi-
cant impact on hospital mortality in individuals ≥ 65
years subjected to MV. This finding, which is in line
with the data reported by Lagu et al. [16], also suggests
the use of MV in persons with dementia in our country
complies (at least in terms of mortality as an effect
Fig. 1 Trends in invasive mechanical ventilation incidence rates in patients with and without dementia. The figure shows the changes observed
over time in incidence rates. The cohort with dementia reaches a greater increase than the cohort without dementia
Fig. 2 Trends in in-hospital mortality in MV episodes of patients with and without dementia. The figure shows the changes observed over time
in in-hospital mortality. Note that cases with dementia do not show the downward trend detected in the cases without dementia; rather, they
feature a fluctuating trend over the period of study
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measure) with the quality standard of its use in patients
≥ 65 years without dementia.
Our trends analysis, nevertheless, indicates that while
hospital mortality in the dementia-free cohort has stead-
ily declined over the 14 years examined, which is consist-
ent with literature reports [35], we observed no parallel
changes in the dementia cohort.
Something similar can be said about the trend ob-
served in the use of hospital resources. While some
studies have shown that dementia leads to longer mean
hospital stay and costs in older patients admitted
because of acute illness [3, 4], our finding is consistent
with more recent descriptions [16, 36] that these vari-
ables are significantly lower in patients with dementia.
Our study also reveals that this reduced resource use in
patients with dementia persists when the extent of MV
was introduced as a covariate in the adjusted multivari-
ate model. Additionally, trend analysis indicate that
mean length of stay difference has increased over the
years since while the mean hospital stay in cases without
dementia has remained stable, it has progressively de-
creased in cases with dementia.
Unfortunately, the database design prevents any causal
inferences or assessment of other reasons that could jus-
tify these trends, such as the existence of advanced
directives, family preferences, or clinical practices toward
the limitation of therapeutic efforts and the use, instead,
of comfort measures. We consider those data are funda-
mental and that it is necessary to study them in a pro-
spective way.
Our observations extend the scarce available informa-
tion on the incidence and short-term outcomes of the
use of invasive technologies such as MV in adults aged
≥ 65 years with dementia, and perhaps, they can be of
help in the existing debate about the use of these thera-
peutic measures in patients with dementia. Further,
given the national population-based nature of our data,
we feel they may be generalizable and of interest for
clinical decision making and healthcare resource plan-
ning in an increasingly aging society for which a greater
prevalence of dementia is foreseen in the near future
[15, 37, 38].
Limitations
Our study has several limitations we should mention.
When working with clinical-administrative data, sensi-
tivity to detect the variables of interest depends directly
on the discharge report completed by the responsible
physician. There is evidence to suggest that dementia
has been undercoded in discharge reports, especially in
mild or complex cases [39]. To minimize this limitation,
we used a broad definition of dementia in line with pre-
vious, similar studies [14, 16], even though these defini-
tions have not been validated against clinical charts.
Fig. 3 Trends in hospital resources in patients with and without dementia. a Over the period examined, geometric mean hospital stay has
decreased significantly in cases with dementia passing from 12.12 days in the year 2000 to 9.47 days in 2013. In contrast, in cases without
dementia, mean stay has remained stable passing from 13.63 to 13.26. b Over the period examined, geometric mean costs per case in the group
with dementia have risen significantly from 6305€ in 2000 to 11,384€ in 2013 and in cases without dementia from 7485€ to 15,583€
(both p < 0.001)
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Moreover, MV is a major procedure which is easily iden-
tified in a patient’s clinical record and whose ICD-9-CM
codes are stable and validated [20]. However, we did
not have access to staging information of our demen-
tia cases. Given that an inverse relationship has been
established between dementia severity and the fre-
quency at which patients are hospitalized and that
some clinical guidelines emphasize the need to treat
persons with dementia at their homes [37], it is likely
that our dementia cohort will contain a high propor-
tion of mild-moderate severity cases. Our data source
also prevents us from knowing other individual fac-
tors such as pharmacological treatments; the existence
of an advance directive or their socio-cultural or edu-
cational level which makes it impossible to further
characterize this cohort and stratify the results ac-
cording to these factors. Nonetheless, given the uni-
versal character of our national health system with
equal access to the whole population, aspects such as
the socioeconomic level have not influenced the re-
sults obtained. Likewise, given the regulation of our
national health system, we can assume that clinical
and coding practices have not been related to eco-
nomic incentives. Also, our database does not include
physiology-based scores of common use in ICUs, such
as APACHE or SAPS. Notwithstanding, Christensen
and colleagues have shown that the Charlson comor-
bidity index performs similarly to physiology-based
scores at predicting short- and long-term mortality
for ICU patients [34]. Finally, because of this study’s
retrospective nature, we cannot rule out that temporal
trends may, at least in part, be associated with differ-
ent treatment practices during the long period of
study. However, the population nature of our study,
its main strength, means we can assume a lack of se-
lection bias and can also extrapolate its results. In
addition, RECORD recommendations for reporting of
results were followed [40].
Conclusions
This nationwide population-based study reveals no
impact of dementia on in-hospital mortality in elderly
patients undergoing invasive mechanical ventilation.
However, dementia is significantly associated with
shorter stay and hospital costs. Our data also identi-
fies a recent marked increase in the use of this life-
support measure in elderly patients with dementia
and that this increase is much greater than that ob-
served in elderly individuals without dementia. This
data have important implications for clinical decision-
making and healthcare resource planning in an in-
creasingly aging society for which a greater prevalence
of dementia is foreseen in the near future.
Additional file
Additional file 1: Table S1. General characteristics and outcomes of
cases by duration of invasive mechanical ventilation (MV). (DOCX 16 kb)
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